Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001069530-23-000004
Filing Date
2023-02-07
Accepted
2023-02-07 17:02:09
Documents
1
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT certent-form5.html 5  
1 PRIMARY DOCUMENT certent-form5.xml 5 4294
  Complete submission text file 0001069530-23-000004.txt   5686
Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Issuer) CIK: 0001069530 (see all company filings)

EIN.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
BARBIER REMI (Reporting) CIK: 0001133806 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-29959 | Film No.: 23595942